The protein arginine methyltransferase Prmt5 is required for myogenesis because it facilitates ATP-dependent chromatin remodeling

被引:149
作者
Dacwag, Caroline S.
Ohkawa, Yasuyuki
Pal, Sharmistha
Sif, Said
Imbalzano, Anthony N.
机构
[1] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA
[2] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA
关键词
D O I
10.1128/MCB.01528-06
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Skeletal muscle differentiation requires the coordinated activity of transcription factors, histone modifying enzymes, and ATP-dependent chromatin remodeling enzymes. The type II protein arginine methyltransferase Prmt5 symmetrically dimethylates histones H3 and H4 and numerous nonchromatin proteins, and prior work has implicated Prmt5 in transcriptional repression. Here we demonstrate that MyoD-induced muscle differentiation requires Prmt5. One of the first genes activated during differentiation encodes the myogenic regulator myogenin. Prmt5 and dimethylated H3R8 (histone 3 arginine 8) are localized at the myogenin promoter in differentiating cells. Modification of H3R8 required Prmt5, and reduction of Prmt5 resulted in the abrogation of promoter binding by the Brg1 ATPase-associated with the SWI/SNF chromatin remodeling enzymes and all subsequent events associated with gene activation, including increases in chromatin accessibility and stable binding by MyoD. Prmt5 and dimethylated H3R8 were also associated with the myogenin promoter in activated satellite cells isolated from muscle tissue, further demonstrating the physiological relevance of these observations. The data indicate that Prmt5 facilitates myogenesis because it is required for Brg1-dependent chromatin remodeling and gene activation at a locus essential for differentiation. We therefore conclude that a histone modifying enzyme is necessary to permit an ATP-dependent chromatin remodeling enzyme to function.
引用
收藏
页码:384 / 394
页数:11
相关论文
共 55 条
[11]   Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells [J].
Cornelison, DDW ;
Wold, BJ .
DEVELOPMENTAL BIOLOGY, 1997, 191 (02) :270-283
[12]   Crosstalk between CARM1 methylation and CBP acetylation on histone H3 [J].
Daujat, S ;
Bauer, UM ;
Shah, V ;
Turner, B ;
Berger, S ;
Kouzarides, T .
CURRENT BIOLOGY, 2002, 12 (24) :2090-2097
[13]   EXPRESSION OF A SINGLE TRANSFECTED CDNA CONVERTS FIBROBLASTS TO MYOBLASTS [J].
DAVIS, RL ;
WEINTRAUB, H ;
LASSAR, AB .
CELL, 1987, 51 (06) :987-1000
[14]   Mammalian SWI-SNF complexes contribute to activation of the hsp70 gene [J].
De la Serna, IL ;
Carlson, KA ;
Hill, DA ;
Guidi, CJ ;
Stephenson, RO ;
Sif, S ;
Kingston, RE ;
Imbalzano, AN .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (08) :2839-2851
[15]   MyoD can induce cell cycle arrest but not muscle differentiation in the presence of dominant negative SWI/SNF chromatin remodeling enzymes [J].
de la Serna, IL ;
Roy, K ;
Carlson, KA ;
Imbalzano, AN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) :41486-41491
[16]   Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation [J].
de la Serna, IL ;
Carlson, KA ;
Imbalzano, AN .
NATURE GENETICS, 2001, 27 (02) :187-190
[17]   MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNA-bound complex [J].
de la Serna, IL ;
Ohkawa, Y ;
Berkes, CA ;
Bergstrom, DA ;
Dacwag, CS ;
Tapscott, SJ ;
Imbalzano, AN .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (10) :3997-4009
[18]   Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers [J].
de la Serna, Ivana L. ;
Ohkawa, Yasuyuki ;
Imbalzano, Anthony N. .
NATURE REVIEWS GENETICS, 2006, 7 (06) :461-473
[19]   Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment [J].
Dhawan, J ;
Rando, TA .
TRENDS IN CELL BIOLOGY, 2005, 15 (12) :666-673
[20]   Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes [J].
Doan, DN ;
Veal, TM ;
Yan, ZJ ;
Wang, WD ;
Jones, SN ;
Imbalzano, AN .
ONCOGENE, 2004, 23 (19) :3462-3473